Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROSIGLITAZONE vs ROXITHROMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROSIGLITAZONE vs ROXITHROMYCIN: Safety Overview

Metric ROSIGLITAZONE ROXITHROMYCIN
Total FAERS Reports 45,976 352
Deaths Reported 4,661 43
Death Rate 10.1% 12.2%
Hospitalizations 23,675 189
Average Patient Age 60.2 yrs 57.9 yrs
% Female Patients 42.8% 57.9%
FDA Approval Date Jan 25, 2013 N/A
Marketing Status Discontinued N/A